A technical note and report of two patients with acute aortic syndrome who were treated with the new generation Ankura thoracic stent graft
Abstract Initial experience with the new generation thoracic endograft (Ankura, Lifetech) in acute aortic syndrome was encouraging. The device was both user‐friendly and safe and it will increase the armamentory of the available endovascular treatment options.
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-06-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.4185 |